Chinese Markets for Anti-Dermatomycosis Skin Drugs

Publication Date	February 2009
Publisher	AMID
Product Type	Report
Pages	173
ISBN Number	not applicable
Product Code	AMI00377

Buy this product or for assistance call +44 20 7060 7474

PDF £2,405.00$4001 | €2692

FAX Order above formats by FAX

Summary

China's demand for Anti-Dermatomycosis Skin Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-term forecasts throught 2013 and 2018 are presented. Major producers in China are profiled.

Content

I. INTRODUCTION
- Report Scope and Methodology
- Executive Summary
II. BUSINESS ENVIRONMENT
- Economic Outlook
- Key Economic Indicators
- Industrial Output
- Population and Labor
- Foreign Investment
- Foreign Trade
- Financial and Tax Regulations
- Banking System and Regulations
- Foreign Exchange
- Taxes, Tariff and Custom Duties
III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS
- Anti Dermatomycosis Skin Drugs Industry Structure
- Market Size
- Market Growth Driver
- Anti Dermatomycosis Skin Drugs Sales Volume
- Major Producer Facility Locations and Sales Volume
- Market Share of Key Producers
- Labor Cost
- Potential Entrants
- Major Distributors
- Major Foreign Investments
- Technology Development
IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND
- Overview
- Demand of Anti Dermatomycosis Skin Drugs by Region in 2008
- Anti Dermatomycosis Skin Drugs Sales Volume
- Fluconazole Sales volume and market share
- Itraconazole Sales volume and market share
- Terbinafine Sales volume and market share
- Econazole Sales volume and market share
- Miconazole Nitrate Sales volume and market share
- Amphotericin B Sales volume and market share
- Ketoconazole Sales volume and market share
- Clotrimazole Sales volume and market share
- Caspofungin Sales volume and market share
- Other Anti Dermatomycosis Skin Drugs Sales volume and market share
- Anti Dermatomycosis Skin Drugs Imports and Exports
- Pricing Trends
V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK
- Anti Dermatomycosis Skin Drugs Markets Outlook Overview Concrete Government Regulations
- Health Care Insurance Industry Overview
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
VI. MARKET ENTRY CHANNELS
- China Market Entry Overview
- China's Distribution System
- Anti Dermatomycosis Skin Drugs Distribution Channels
- Transportation and Freight Infrastructure
- Communications
- China's Market Entry
- Export to China
- Indirect export
- Direct Export
- License and Contract Manufacture
- Assembling in China
- Contract Manufacturing
- Trade Permit
- Investment
- Equity Joint Venture
- Contractual Joint Venture
- Wholly Foreign-Owned Enterprise
VII. ANTIFREEZE & THAWING AGENT PRODUCER DIRECTORY
- Anti Dermatomycosis Skin Drugs Producer Profiles and Directory
LIST OF TABLES
I. INTRODUCTION
- Economic Outlook Summary
II. BUSINESS ENVIRONMENT
- Key Economic Indicators
- Industrial Output
- Population and Labor Force Trends
- Foreign Investment and Loans
- Foreign Trade
III. ANTI DERMATOMYCOSIS SKIN DRUGS INDUSTRY ASSESSMENTS
- Anti Dermatomycosis Skin Drugs Sales Volume
- Major Producer Facility Locations
- Major Anti Dermatomycosis Skin Drugs Producer Sales Volume
- Market Share of Key Producers
- Major Foreign Investments
IV. ANTI DERMATOMYCOSIS SKIN DRUGS PRODUCTION AND DEMAND
V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK
- Consumer Spending Trends
- Demographic Trends
- Health Care Industry Trends
- Hospitals and Hospital Beds
- Physicians and Physician Visits
LIST OF CHARTS
I. INTRODUCTION
- Anti Dermatomycosis Skin Drugs Sales Volume
II. BUSINESS ENVIRONMENT
- China's GDP and Growth Rate
- Industrial Output by Ownership
- China's Imports and Exports
III. ANTIFREEZE & THAWING AGENT INDUSTRY ASSESSMENTS
- Anti Dermatomycosis Skin Drugs Sales Volume
IV. ANTIFREEZE & THAWING AGENT PRODUCTION AND DEMAND
- Anti Dermatomycosis Skin Drugs Sales Volume
- Worldwide Anti Dermatomycosis Skin Drugs Demand by region
- Fluconazole Sales Volume and Market Share
- Itraconazole Sales Volume and Market Share
- Terbinafine Sales Volume and Market Share
- Econazole Sales Volume and Market Share
- Miconazole Sales Volume and Market Share
- Amphotericin B Sales Volume and Market Share
- Ketoconazole Sales Volume and Market Share
- Clotrimazole Sales Volume and Market Share
- Caspofungin Sales Volume and Market Share
- Other Anti Dermatomycosis Skin Drugs Sales Volume and Market Share
- Anti Dermatomycosis Skin Drugs Import, Export and Net Import
- Fluconazole Import, Export and Net Import
- Itraconazole Import, Export and Net Import
- Terbinafine Import, Export and Net Import
- Econazole Import, Export and Net Import
- Miconazole Nitrate Import, Export and Net Import
- Amphotericin B Import, Export and Net Import
- Ketoconazole Import, Export and Net Import
- Clotrimazole Import, Export and Net Import
- Caspofungin Import, Export and Net Import
- Other Import, Export and Net Import
V. ANTI DERMATOMYCOSIS SKIN DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
- China's Distribution Channel